CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Contraception - emergency - Management
Is oral ulipristal acetate emergency contraception suitable for mothers who are breastfeeding?
- It is not known whether ulipristal acetate is excreted in breast milk, so breastfeeding women are advised not to breastfeed for 36 hours after treatment [ABPI Medicines Compendium, 2009].
- Oral levonorgestrel can be considered in a breastfeeding mother for emergency contraception as it is not thought to be harmful to babies [FFPRHC, 2004b; FFPRHC, 2006a].
- A copper intrauterine device could also be considered for emergency contraception in women more than 4 weeks postpartum.
© NHS Institute for Innovation and Improvement